Mapping depression rating scale phenotypes onto research domain criteria (RDoC) to inform biological research in mood disorders.
暂无分享,去创建一个
A. Rush | M. Frye | R. Weinshilboum | Liewei Wang | H. Mayberg | R. Krishnan | A. Ahmed | J. Biernacka | W. E. Craighead | W. McDonald | W. Bobo | P. Riva-Posse | S. Tye | D. Hall-Flavin | M. Skime | G. Jenkins | R. Kaddurah-Daouk | B. Dunlop | A. T. Ahmed | D. Hall‐Flavin
[1] M. Hamilton. A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.
[2] R. R. Parker,et al. Response to phenelzine and amitriptyline in subtypes of outpatient depression. , 1982, Archives of general psychiatry.
[3] A. Beck,et al. Psychometric properties of the Beck Depression Inventory: Twenty-five years of evaluation , 1988 .
[4] R. Fieve,et al. Melancholic/endogenous depression and response to somatic treatment and placebo. , 1992, The American journal of psychiatry.
[5] R. Kessler,et al. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. , 1996, Archives of general psychiatry.
[6] M. Fava,et al. Major depressive subtypes and treatment response , 1997, Biological Psychiatry.
[7] P. Sullivan,et al. Latent class analysis of lifetime depressive symptoms in the national comorbidity survey. , 1998, The American journal of psychiatry.
[8] P. Mitchell,et al. Subtyping depression: testing algorithms and identification of a tiered model. , 1999, The Journal of nervous and mental disease.
[9] M. Fava,et al. Timing of onset of antidepressant response with fluoxetine treatment. , 2000, The American journal of psychiatry.
[10] P. Sullivan,et al. The subtypes of major depression in a twin registry. , 2002, Journal of affective disorders.
[11] F. Quitkin. Depression With Atypical Features: Diagnostic Validity, Prevalence, and Treatment. , 2002, Primary care companion to the Journal of clinical psychiatry.
[12] F. Benazzi. Can only reversed vegetative symptoms define atypical depression? , 2002, European Archives of Psychiatry and Clinical Neuroscience.
[13] J. Markowitz,et al. The 16-Item quick inventory of depressive symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression , 2003, Biological Psychiatry.
[14] R. Bagby,et al. The Hamilton Depression Rating Scale: has the gold standard become a lead weight? , 2004, The American journal of psychiatry.
[15] A. Gamma,et al. Atypical depressive syndromes in varying definitions , 2006, European Archives of Psychiatry and Clinical Neuroscience.
[16] Alan B. Shafer,et al. Meta-analysis of the factor structures of four depression questionnaires: Beck, CES-D, Hamilton, and Zung. , 2006, Journal of clinical psychology.
[17] M. Fava,et al. Response to a selective serotonin reuptake inhibitor (citalopram) in major depressive disorder with melancholic features: a STAR*D report. , 2008, The Journal of clinical psychiatry.
[18] G. Parker,et al. Measuring melancholia: the utility of a prototypic symptom approach , 2008, Psychological Medicine.
[19] A. Beekman,et al. Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA). , 2010, The Journal of clinical psychiatry.
[20] A. Beekman,et al. Stability and transitions of depressive subtypes over a 2-year follow-up , 2012, Psychological Medicine.
[21] Helen S Mayberg,et al. Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial , 2012, Trials.
[22] G. Chrousos,et al. Melancholic and atypical subtypes of depression represent distinct pathophysiological entities: CRH, neural circuits, and the diathesis for anxiety and depression , 2013, Molecular Psychiatry.
[23] A. Franco,et al. Toward a neuroimaging treatment selection biomarker for major depressive disorder. , 2013, JAMA psychiatry.
[24] D. Schaid,et al. Treatment Outcomes of Depression: The Pharmacogenomic Research Network Antidepressant Medication Pharmacogenomic Study , 2014, Journal of clinical psychopharmacology.
[25] Donna M. Palmer,et al. Depression Subtypes in Predicting Antidepressant Response: A Report From the iSPOT-D Trial. , 2015, The American journal of psychiatry.
[26] B. Gibb,et al. Integrating NIMH Research Domain Criteria (RDoC) into Depression Research. , 2015, Current opinion in psychology.
[27] Prediction of treatment outcomes in major depressive disorder. , 2015, Expert review of clinical pharmacology.
[28] E. Eriksson,et al. Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression , 2015, Molecular Psychiatry.
[29] Carolyn R Rohrer Vitek,et al. Pharmacokinetic Pharmacogenetic Prescribing Guidelines for Antidepressants: A Template for Psychiatric Precision Medicine. , 2016, Mayo Clinic proceedings.
[30] Helen S Mayberg,et al. Effects of Patient Preferences on Outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) Study. , 2017, The American journal of psychiatry.
[31] Helen S Mayberg,et al. Functional Connectivity of the Subcallosal Cingulate Cortex And Differential Outcomes to Treatment With Cognitive-Behavioral Therapy or Antidepressant Medication for Major Depressive Disorder. , 2017, The American journal of psychiatry.
[32] H. Walter,et al. Research Domain Criteria (RDoC) , 2017, Der Nervenarzt.
[33] Ulrike Kübler. Structured Clinical Interview for DSM-IV (SCID) , 2020, Encyclopedia of Behavioral Medicine.